We are live on ! Find out more
AQR Capital Management

AQR Capital Management Portfolio holdings

AUM $218B
1-Year Est. Return 29.41%
This Fund
S&P 500
This Quarter Est. Return
+1%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$65.2B
AUM Growth
+$6.51B
Cap. Flow
+$6.71B
Cap. Flow %
10.29%
Top 10 Hldgs %
15.4%
Holding
2,716
New
313
Increased
1,389
Reduced
876
Closed
123

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$213M
2
CI icon
Cigna
CI
+$207M
3
CMCSA icon
Comcast
CMCSA
+$164M
4
ZM icon
Zoom
ZM
+$155M
5
JNJ icon
Johnson & Johnson
JNJ
+$139M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$237M
2
TSM icon
TSMC
TSM
+$214M
3
NVDA icon
NVIDIA
NVDA
+$138M
4
ADBE icon
Adobe
ADBE
+$133M
5
PHM icon
Pultegroup
PHM
+$124M

Sector Composition

Rank Sector Weight
1 Technology 24.59%
2 Financials 13.87%
3 Industrials 12.52%
4 Consumer Discretionary 12.44%
5 Healthcare 12.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HYPD
2576
Hyperion DeFi Inc
HYPD
$39.6M
$16.1K ﹤0.01%
+338
New +$19.6K
GEVO icon
2577
Gevo
GEVO
$382M
$15.9K ﹤0.01%
28,526
-89,766
-76% -$60.1K
OKUR
2578
OnKure Therapeutics
OKUR
$164M
$15.7K ﹤0.01%
+1,040
New +$17.6K
AKTS
2579
DELISTED
Akoustis Technologies Inc
AKTS
$14.6K ﹤0.01%
110,702
+95,264
+617% +$35.9K
MKTW icon
2580
MarketWise
MKTW
$55.3M
$14.6K ﹤0.01%
+628
New +$18.5K
ZVIA icon
2581
Zevia
ZVIA
$108M
$14K ﹤0.01%
+20,745
New +$19.2K
XAIR icon
2582
Beyond Air
XAIR
$3.75M
$12K ﹤0.01%
+56
New +$27.9K
PIII icon
2583
P3 Health Partners
PIII
$42.7M
$11.8K ﹤0.01%
+525
New +$15.7K
VOR icon
2584
Vor Biopharma
VOR
$1.27B
$11.2K ﹤0.01%
+560
New +$18.1K
SKYX icon
2585
SKYX Platforms
SKYX
$164M
$10.9K ﹤0.01%
+11,473
New +$11.2K
SGMO
2586
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$10.6K ﹤0.01%
29,535
-843
-3% -$455
VATE icon
2587
INNOVATE Corp
VATE
$97.3M
$9.58K ﹤0.01%
+1,584
New +$10.5K
BIRD icon
2588
Smartbird Inc
BIRD
$22.7M
$9.53K ﹤0.01%
+953
New +$11.6K
DNMR
2589
DELISTED
Danimer Scientific, Inc.
DNMR
$9.48K ﹤0.01%
+393
New +$12.2K
BHIL
2590
DELISTED
Benson Hill, Inc.
BHIL
$9.4K ﹤0.01%
1,763
+569
+48% +$3.77K
TVRD
2591
Tvardi Therapeutics
TVRD
$22M
$8.52K ﹤0.01%
917
+116
+14% +$2.77K
BIVI icon
2592
BioVie
BIVI
$8.3M
$8.07K ﹤0.01%
+202
New +$9.67K
LPTV
2593
DELISTED
Loop Media, Inc.
LPTV
$3.62K ﹤0.01%
+35,813
New +$8.83K
ACHC icon
2594
Acadia Healthcare
ACHC
$2.96B
-3,536
Closed -$279K
ACVA icon
2595
ACV Auctions
ACVA
$1.27B
-17,060
Closed -$320K
AEHR icon
2596
Aehr Test Systems
AEHR
$3.46B
-91,139
Closed -$1.13M
ALB icon
2597
Albemarle
ALB
$15.5B
-1,822
Closed -$236K
ALLK
2598
DELISTED
Allakos
ALLK
-180,318
Closed -$227K
AMC icon
2599
AMC Entertainment Holdings
AMC
$2.16B
-244,737
Closed -$910K
AMRC icon
2600
Ameresco
AMRC
$1.34B
-12,634
Closed -$305K

Similar funds

AQR Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, AQR Capital Management held 2,716 positions worth $65.2B, up 11% from $58.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

AQR Capital Management deployed $6.71B of net new capital in Q2 2024, opening 313 new positions and adding to 1,389 existing holdings. Its largest new stake was Solventum: 1,217,998 shares worth $62.6M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Humana, an estimated $237M trimmed.

  • AQR Capital Management's largest Q2 2024 buy was Solventum: 1,217,998 shares worth $62.6M.
  • AQR Capital Management added most to ExxonMobil in Q2 2024, an estimated $213M increase.
  • AQR Capital Management's biggest Q2 2024 reduction was Humana, cutting an estimated $237M.
  • AQR Capital Management fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $27.7M.
  • AQR Capital Management's ten largest holdings make up 15% of its $65.2B portfolio in Q2 2024.
  • AQR Capital Management opened 313 new positions and closed 123 in Q2 2024.
  • AQR Capital Management's portfolio value rose 11% quarter-over-quarter to $65.2B.

Based on AQR Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.